{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:09:51Z","timestamp":1648685391610},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.transproceed.2018.04.023","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T13:48:01Z","timestamp":1523540881000},"page":"2457-2460","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early Outcomes of Living-Donor Kidney Transplantation With Immunosuppression Therapy Induction With Tacrolimus Extended-Release: A Comparison With Cyclosporine"],"prefix":"10.1016","volume":"50","author":[{"given":"O.","family":"Konno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2018.04.023_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/01.TP.0000110408.83054.88","article-title":"Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review","volume":"77","author":"Butler","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.04.023_bib2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.TP.0000437669.93963.8E","article-title":"Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release\/MMF, tacrolimus\/MMF, and cyclosporine\/MMF in de novo kidney transplant recipients","volume":"97","author":"Silva","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.04.023_bib3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1600-6143.2009.02987.x","article-title":"Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups","volume":"10","author":"Sis","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.04.023_bib4","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.transproceed.2009.06.070","article-title":"Conversion to tacrolimus extended-release formulation: short-term clinical results","volume":"41","author":"Gallego-Valcarce","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.04.023_bib5","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.transproceed.2009.05.014","article-title":"De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels","volume":"41","author":"Crespo","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.04.023_bib6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1600-6143.2004.00383.x","article-title":"Pharmacokinetics of tacrolimus in kidney transplant recipients: twice daily versus once daily dosing","volume":"4","author":"Hardinger","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.04.023_bib7","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.transproceed.2005.02.104","article-title":"Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapy","volume":"37","author":"Iwahori","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.04.023_bib8","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/TP.0b013e3182a203bd","article-title":"Optimising immunoSuppression After Kidney transplantation with ADVAGRAF Study Group. OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation","volume":"96","author":"Albano","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.04.023_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clpt.2005.04.008","article-title":"Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients","volume":"78","author":"Fukudo","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2018.04.023_bib10","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N\u00a0Engl J Med"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451830592X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113451830592X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T01:27:15Z","timestamp":1539221235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113451830592X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S004113451830592X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.04.023","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Outcomes of Living-Donor Kidney Transplantation With Immunosuppression Therapy Induction With Tacrolimus Extended-Release: A Comparison With Cyclosporine","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}